Milford, MA – Prestige Scientific is excited to announce the successfully completed search of a Senior Vice President of CMC and Formulations, for our partner, a clinical-stage, publicly traded biotechnology company developing therapies for CNS diseases through their proprietary platform.
The selected candidate, brings a wealth of experience as an executive strategic and technical leader in pharmaceutical development, spanning pre-clinical stages through post-commercial activities for both small molecules and biologics, including global regulatory filings. They have a proven track record of building and leading high-performing teams, effectively managing multiple projects across diverse operational models encompassing internal manufacturing capabilities and fully outsourced environments.
"We are delighted to have played a pivotal role in securing our partner’s Senior Vice President of CMC and Formulations," said Mike Smith, Partner and CMC Practice Leader at Prestige Scientific. "This successful placement underscores Prestige Scientific's commitment to delivering top-tier leadership talent to meet the evolving needs of our clients in the biopharmaceutical industry."
The search for our partner posed unique challenges due to the requirement for relocation and the specialized skill set needed. Prestige Scientific presented four highly qualified individuals for this role, the hired candidate was presented 20 days from the start of the search, and the search was completed in 37 days.
About Prestige Scientific:
Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.
